The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation

Journal of Virology
|November 1, 1984
PubMed

Insights

Polyomavirus middle T antigen induces tumors and cell transformation. Researchers found that the acidic amino acids and tyrosine 315 are not essential for this transforming activity, challenging previous assumptions about its mechanism.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Polyomavirus middle T antigen is crucial for tumor induction and cellular transformation.
  • Understanding the specific domains of middle T antigen involved in its function is key to elucidating its mechanism of action.

Purpose of the Study:

  • To investigate the role of acidic amino acids and tyrosine 315 in the transforming activity of polyomavirus middle T antigen.
  • To determine if these specific regions are essential for the oncogenic potential of the virus.

Main Methods:

  • In vitro mutagenesis was used to create deletions in the DNA sequences encoding specific regions of middle T antigen.
  • Mutant polyomaviruses were tested for their ability to transform Rat-1 cells in culture.
  • Transformed Rat-1 cells were assessed for their capacity to form tumors in vivo.

Main Results:

  • Five out of seven constructed mutants were incapable of transforming Rat-1 cells due to reading frame alterations.
  • Two mutants, pPdl1-4 and pPdl2-7, retained high transforming frequencies.
  • Mutant pPdl1-4 lacked part of the acidic amino acid stretch but retained tyrosine 315; mutant pPdl2-7 lacked both the acidic stretch and tyrosine 315.
  • Cells transformed by these mutants exhibited a fully transformed phenotype and formed tumors.

Conclusions:

  • The major site of tyrosine phosphorylation (tyrosine 315) in polyomavirus middle T antigen is not essential for its transforming activity.
  • The preceding stretch of acidic amino acids is also not required for the transforming capabilities of middle T antigen.
  • These findings suggest alternative mechanisms or domains are responsible for the oncogenic functions of middle T antigen.